Hardeep Singh
Psychiatry · Tampa, FLNPI 1386708675
Payments from drug & device makers
Across 1,055 payments — averaging $354.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$147K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$70K
- Axsome Therapeutics, Inc.$63K
- E.r. Squibb & Sons, L.L.C.$45K
- Supernus Pharmaceuticals, Inc.$32K
- Johnson & Johnson$7K
- plus $10K from 31 others
What the payments were for
- Consulting fees$73,58820%
- Speaking & faculty fees$255,71068%
- Travel & lodging$21,5116%
- Food & beverage$23,5156%
- Education$150%
- Gifts$00%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$374,339 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 53 | $80,259 |
| TrintellixVortioxetine Hydrobromide | 17 | $10,629 |
| Adderall XrDextroamphetamine/Amphetamine | 13 | $7,741 |
| XanaxAlprazolam | 12 | $7,637 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 239 | $5,861 |
| Aripiprazole | 116 | $5,622 |
| Alprazolam | 810 | $4,769 |
| Methylphenidate Hcl | 59 | $4,344 |
| Clonazepam | 337 | $2,995 |
| Duloxetine Hcl | 171 | $2,411 |
| Bupropion XlBupropion Hcl | 97 | $1,897 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 31 | $1,852 |
| Quetiapine Fumarate | 119 | $1,735 |
| Trazodone Hcl | 181 | $1,598 |
| Clozapine | 24 | $1,541 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $147,312 | $80,25953 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $262 | $10,62917 claims |
| Almatica Pharma LLCSertraline Hcl | $268 | $951152 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Tampa
- Kelley WilsonTampa$11.1M
- Jamie FernandezTampa$2.9M
- Jean FilsTampa$1.1M
- Daniel FallonTampa$724K
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.